Literature DB >> 19669239

Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas.

Wei-Wen Su1, Chien-Hung Chen, Hans Hsienhong Lin, Sheng-Shun Yang, Ting-Tsung Chang, Ken-Sheng Cheng, Jaw-Ching Wu, Shun-Sheng Wu, Chuan-Mo Lee, Chi-Sin Changchien, Chien-Jen Chen, Jin-Chuan Sheu, Ding-Shinn Chen, Sheng-Nan Lu.   

Abstract

PURPOSE: The proportion of B-HCC cases in Taiwan has progressively decreased over the last 20 years. It was not really due to an overall decrease in B-HCC but due to an increase in HCV-related HCC. The identification of potential HCV endemic areas in Taiwan has consequently become important.
METHODS: Data were collected retrospectively from eight Taiwan medical centers from 1981 to 2001, the geographical variations of male C-HCC townships in Taiwan were illustrated on maps. Goodness of fit was used to compare the anti-HCV prevalence in townships and cities, with the mean anti-HCV prevalence for Taiwan as a whole. Township-, city-, and county-specific prevalence of anti-HCV was presented as the median, ranges, and SMRs.
RESULTS: Geographic variation can be analyzed in only 263 townships and cities. The maps were designed on the basis of different SMRs. The mean anti-HCV prevalence for male HCC patients in Taiwan was 31.9% (95% confidence interval: 30.7-33.0). Twenty-five townships distributed throughout central-western and south-western Taiwan have significantly higher prevalence (P < 0.05) (12 townships SMR >/= 2; 13 townships 1.5 </= SMR < 2). Twenty-two townships have significantly lower prevalence (P < 0.05) (6 townships 0.5 </= SMR<1; 16 townships SMR < 0.5). Four different patterns of geographic variation in different counties were also noted and demonstrated.
CONCLUSION: We successfully highlighted some potential high HCV endemic townships in Taiwan.

Entities:  

Year:  2009        PMID: 19669239      PMCID: PMC2790586          DOI: 10.1007/s12072-009-9146-x

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  18 in total

1.  Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan.

Authors:  S N Lu; P Y Chue; H C Chen; M H Wu; I L Chen; J F Huang; J H Wang; C F Peng; C H Shih; S L You; C F Lu; C J Chen; W Y Chang
Journal:  J Gastroenterol Hepatol       Date:  1997-07       Impact factor: 4.029

2.  Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.

Authors:  Meng-Chin Tsai; Kwong-Ming Kee; Yao-Der Chen; Li-Chu Lin; Lin-San Tsai; Hsiu-Hsi Chen; Sheng-Nan Lu
Journal:  J Gastroenterol Hepatol       Date:  2007-01       Impact factor: 4.029

3.  Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan.

Authors:  C S Wang; T T Chang; P Chou
Journal:  J Clin Epidemiol       Date:  1998-09       Impact factor: 6.437

Review 4.  Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials.

Authors:  Jesper Brok; Lise L Gluud; Christian Gluud
Journal:  Arch Intern Med       Date:  2005-10-24

5.  Excess mortality from hepatocellular carcinoma in an HCV-endemic township of an HBV-endemic country (Taiwan).

Authors:  S N Lu; C M Lee; C S Changchien; C J Chen
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Nov-Dec       Impact factor: 2.184

6.  Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors.

Authors:  C A Sun; H C Chen; S N Lu; C J Chen; C F Lu; S L You; S H Lin
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

Review 7.  Hepatocellular carcinoma: recent trends in the United States.

Authors:  Hashem B El-Serag
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

8.  Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan.

Authors:  Sheng-Nan Lu; Wei-Wen Su; Sheng-Shun Yang; Ting-Tsung Chang; Ken-Sheng Cheng; Jaw-Ching Wu; Hans Hsienhong Lin; Shun-Sheng Wu; Chuan-Mo Lee; Chi-Sin Changchien; Chien-Jen Chen; Jin-Chuan Sheu; Ding-Shinn Chen; Chien-Hung Chen
Journal:  Int J Cancer       Date:  2006-10-15       Impact factor: 7.396

9.  Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants.

Authors:  Chien-Hung Chen; Pei-Ming Yang; Guan-Tarn Huang; Hsuan-Shu Lee; Juei-Low Sung; Jin-Chuan Sheu
Journal:  J Formos Med Assoc       Date:  2007-02       Impact factor: 3.282

Review 10.  Global control of hepatitis B virus infection.

Authors:  Jia-Horng Kao; Ding-Shinn Chen
Journal:  Lancet Infect Dis       Date:  2002-07       Impact factor: 25.071

View more
  2 in total

1.  Using AST-platelet ratio index and fibrosis 4 index for detecting chronic hepatitis C in a large-scale community screening.

Authors:  Yuan-Hung Kuo; Kwong-Ming Kee; Nien-Tzu Hsu; Jing-Houng Wang; Chang-Chun Hsiao; Yi Chen; Sheng-Nan Lu
Journal:  PLoS One       Date:  2019-10-22       Impact factor: 3.240

2.  Geographic Variations and Time Trends in Cancer Treatments in Taiwan.

Authors:  Jason C Hsu; Sheng-Mao Chang; Christine Y Lu
Journal:  BMC Public Health       Date:  2017-08-02       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.